Grovepoint acquires majority stake in biotech firm Algatechnologies

Grovepoint (London), a private investment company, says it has acquired a majority stake in biotech company Algatechnologies (Hevel Eilot, Israel), a rapidly growing firm specializing in the commercial cultivation of microalgae and a leading manufacturer of natural astaxanthin AstaPure.   Astaxanthin is a natural antioxidant with proven health benefits in several health conditions related to joint and muscle function, skin-care health, and cardiovascular health. The product is already well established in Japanese health food and increased recognition of its...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers